Cat. No. | Product name | CAS No. |
DCC5418 |
Virodhamine Trifluoroacetate
Endogenous cannabinoid receptor mixed agonist/antagonist, being a full agonist at GPR55 and CB2 and partial agonist/antagonist at CB1 |
1415264-56-0 |
DCC5419 |
Vitexin 4"-o-glucoside
Natural inhibitor of ST2 (IL1RL1) |
178468-00-3 |
DCC5420 |
Viviren
Coelenterazine analog for bioluminescence imaging (BLI) |
|
DCC5421 |
Vmy-1-101
Fluorescent cyclin-dependent kinase inhibitor, blocking the proliferation of human breast cancer cells |
1209002-42-5 |
DCC5422 |
vmy-2-95
Novel and selective desensitizer of |
1434047-61-6 |
DCC5423 |
Setmelanotide Tfa Salt
Featured
Novel highly-selective melanocortin-4 receptor (MC4R) agonist, increasing resting energy expenditure in obese individuals |
920014-72-8 |
DCC5424 |
Voa Analog 19
Novel potent VEGFR2 modulator, exhibiting increased antiangiogenic potency than voacangine against VEGF-induced VEGFR2 phosphorylation without cytotoxic effects, resulting in significant tumor cell death in a mouse xenograft model |
|
DCC5425 |
Voclosporin
Novel calcineurin inhibitor and immunosuppressive agent |
515814-00-3 |
DCC5426 |
Vonoprazan Fumurate
Novel potassium-competitive acid blocker |
881681-01-2 |
DCC5427 |
Vpc-00628
Novel potent and highly selective type-II inhibitor of p38α/β, targeting an inactive state of the kinases induced by a unique folded P-loop conformation |
|
DCC5428 |
Vpc-13163
Potent Antiandrogen, Targeting the BF3 Site of the Androgen Receptor and Inhibiting Enzalutamide-Resistant Prostate Cancer |
6637-10-1 |
DCC5429 |
Vpc-16606
Novel potent and selective inhibitor of ERα-dependent cell growth and gene expression, preventing the interaction between ERα-LBD and SRC-3 fusion proteins in a dose-dependent manner |
2027540-49-2 |
DCC5430 |
Vpc24191
S1P1/S1P3 receptor agonist |
799268-83-0 |
DCC5431 |
Vpc-3033
Novel Androgen Receptor Antagonist, inhibiting the LNCaP cell line as well as cell lines with wild-type androgen receptor |
110763-24-1 |
DCC5432 |
Vpc44116
Competitive S1P1/3 antagonist, increasing capillary permeability as measured by Evans blue dye leakage in mouse lung tissue |
1161429-70-4 |
DCC5433 |
Vrt-325
Corrector of F508del-cystic fibrosis transmembrane conductance regulator (CFTR) mutant |
815592-21-3 |
DCC5434 |
Vrv-pl-viiia Inhibitor 5m
Inhibitor of the catalytic activity of VRV-PL-VIIIa, strongly inhibiting the hemolysis of red blood cells and VRV-PL-VIIIa-induced myotoxicity and lung hemorrhage in mice |
|
DCC5435 |
Vrx-480773
Novel Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) |
|
DCC5436 |
Vsw1198
Novel inhibitor of geranylgeranyl diphosphate synthase (GGDPS) |
|
DCC5437 |
Vswrapta
Novel Promoter of Neuronal Branching Via Transcellular Activation of the Focal Adhesion Kinase (FAK) and the ERK1/2 Signaling Pathway In Vitro |
2229829-30-3 |
DCC5438 |
Vt-me6
Sphingosine kinase (SphK) inhibitor, having modest SphK2-selectivity |
1353880-00-8 |
DCC5439 |
Vtx-2337 Analog-1
Novel selective agonist of TLR8 |